Source of material
As olution of 4-methylbenzoic acid (7 mmol), N-(3-dimethylaminopropyl)-N'-ethyl-carbodiimide hydrochloride (7.3 mmol), and 4-dimethylaminopyridine (400 mg)indichloromethane (75 mL) was stirred at ambient temperature. (1E)-NHydroxy-3-(1H-imidazol-1-yl)-1-phenylpropan-1-imine( 6.9 mmol) [2] was added to the stirred reaction mixture and stirring was continued for afurther 18 hatroom temperature. The reaction mixturewas washed successivelywithw ater (2´20 mL), 10% NaHCO 3 solution (2´15 mL), and water (2´15 mL). The organic layer was separated, dried (Na 2 SO 4 )and evaporated under reduced pressure and the residue was crystallized from isopropanolt ogive pale yellow crystals of thet itle compound (m.p. 125-127°C [2] ) which were suitable for X-ray crystallography.
Discussion
Fungi are eukaryotic organismsand someofthem are important human pathogensc ausing diseases such as Aspergillosis, Candidosis and Cryptococcosis [3] [4] [5] .Actually, the incidence of severe fungal infections has increased in an alarming way over thelasttwo decades. Azoles arethe largest family of antifungal drugsand they have been andare stillwidelyusedtotreat superficial mucosal as well as deep and disseminated fungal infections. Nevertheless, theirextensiveuse givesrise to the development of resistance andresultedintherapeutic failure. Thetitle compound is an imidazole-containing antifungal agent having MIC value of 0.3752 µmol/mLt owards clinical isolates of Candida albicans and Asperagillus niger.Whereas, it showed MIC value of 0.1876 and 1.5008 µmol/mLt owards clinical isolates of Candida tropicalis and Penicillium chrysogenum,respectively [2] .The E isomer of the title compound as akinetically favored candidate wasdetectedoverthe Z isomerdue to the steric factor. The single bond N1-O2i sc learly characterized by the distance of 1.4382(18) Å. 
